Evidence map›Paper›PMID 40331930›Full record

ArticleInternational journal of molecular sciences2025

In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds' Metabolic and Anti-Tumor Effects.

Lucia Camelia Pirvu, Amalia Stefaniu, Sultana Nita, Nicoleta Radu, Georgeta Neagu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lucia Camelia PirvuDepartment of Pharmaceutical Biotechnologies, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.ORCID 0000-0002-5032-5079
Amalia StefaniuDepartment of Pharmaceutical Biotechnologies, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.ORCID 0000-0002-7254-7991
Sultana NitaDepartment of Physical-Chemical Analysis and Quality Control, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.
Nicoleta RaduBiotechnology Faculty, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti, District 1, 011464 Bucharest, Romania.ORCID 0000-0002-1106-0258
Georgeta NeaguDepartment of Pharmacology, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.ORCID 0000-0003-3087-3892

Funding

"Nucleu" Program, UEFISCDI, Grant no. 1N/2023, Project code PN23-28 BioChemLife" PN23-28 04 01
6 · The paper itself

Abstract

Plant extracts contain many small molecules that are less investigated. The present paper aims to study in silico physical-chemical, pharmacokinetic, medicinal chemistry and lead/drug-likeness properties and the ability to interfere with the activity of P-glycoprotein (P-gp) transporter and cytochrome P450 (CYP) oxidase system in humans of phloridzin, phloretin, 4-methylchalcone metabolic series alongside the top three compounds found in the ethanolic extract from strawberries (S), namely 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one, 2-pyrrolidinone 5-(cyclohexylmethyl) and hexadecanoic acid. The phloridzin derivatives also were studied for their inhibitory potential upon Bcl-2, TNKS1 and COX-2 molecular targets. In vitro, Caco-2 studies analyzed the cytoprotective and anti-proliferative activity of S and the three phloridzin derivatives (pure compounds) in comparison with their combination 1:1 (GAE/pure compound,

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicFragariaPlant ExtractsCaco-2 CellsCell ProliferationChalconesComputer SimulationHumansMolecular Docking SimulationPhloretinPhlorhizinAntineoplastic AgentsAntineoplastic Agents, PhytogenicChalconesPhloretinPhlorhizinPlant Extracts2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one 2-pyrrolidinone 5-(cyclohexylmethyl) and hexadecanoic acid40% ethanolic extract from strawberry fruitsCaco-2in silico CLC docking analysis for Bcl-2 TNKS and COX-2 targetsin silico SwissADME analysisin vitro cytotoxicity and anti-proliferative studiesphloridzin phloretin and 4-methylchalcone

Identifiers

PMID40331930
PMCPMC12026510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.